US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Biohaven Ltd (BHVN)
Biohaven Ltd (BHVN) ニュース

BHVN

Biohaven (BHVN)

Biohaven Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:BHVN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	20 : 30	PR Newswire (US)	Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day	NYSE:BHVN	Biohaven Ltd
2024/05/29	20 : 15	PR Newswire (US)	Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors	NYSE:BHVN	Biohaven Ltd
2024/05/18	05 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2024/05/18	05 : 41	Edgar (US Regulatory)	Form 424B7 - Prospectus [Rule 424(b)(7)]	NYSE:BHVN	Biohaven Ltd
2024/05/10	05 : 16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:BHVN	Biohaven Ltd
2024/05/10	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2024/05/10	05 : 05	PR Newswire (US)	Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments	NYSE:BHVN	Biohaven Ltd
2024/04/23	05 : 05	PR Newswire (US)	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares	NYSE:BHVN	Biohaven Ltd
2024/04/18	05 : 05	PR Newswire (US)	Biohaven Announces Proposed Public Offering of Common Shares	NYSE:BHVN	Biohaven Ltd
2024/04/13	22 : 00	PR Newswire (US)	Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates	NYSE:BHVN	Biohaven Ltd
2024/03/01	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2024/03/01	06 : 05	PR Newswire (US)	Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments	NYSE:BHVN	Biohaven Ltd
2024/01/08	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2024/01/08	21 : 30	PR Newswire (US)	Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncolo	NYSE:BHVN	Biohaven Ltd
2024/01/02	21 : 00	PR Newswire (US)	Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NYSE:BHVN	Biohaven Ltd
2023/12/02	06 : 30	PR Newswire (US)	Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting	NYSE:BHVN	Biohaven Ltd
2023/11/15	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BHVN	Biohaven Ltd
2023/11/15	06 : 05	PR Newswire (US)	Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments	NYSE:BHVN	Biohaven Ltd
2023/10/16	20 : 00	PR Newswire (US)	Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek®	NYSE:BHVN	Biohaven Ltd
2023/10/06	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2023/10/06	05 : 05	PR Newswire (US)	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares	NYSE:BHVN	Biohaven Ltd
2023/10/05	05 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:BHVN	Biohaven Ltd
2023/10/03	12 : 56	PR Newswire (US)	Biohaven Announces Pricing of $225 Million Public Offering of Common Shares	NYSE:BHVN	Biohaven Ltd
2023/10/03	10 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2023/10/03	06 : 09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:BHVN	Biohaven Ltd
2023/10/03	06 : 07	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:BHVN	Biohaven Ltd
2023/10/03	05 : 36	PR Newswire (US)	BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES	NYSE:BHVN	Biohaven Ltd
2023/10/03	05 : 01	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:BHVN	Biohaven Ltd
2023/09/27	19 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BHVN	Biohaven Ltd
2023/09/14	20 : 00	PR Newswire (US)	Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy	NYSE:BHVN	Biohaven Ltd

Showing the most relevant articles for your search:NYSE:BHVN

1 2 3 4 5 6 7 8 9 10 次へ >>

Bank of America

US Dollar vs Sterling

Financial Select Sector

American Express

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約